alexa Editor - Shashwat Sharad | Uniformed Services University of Heal | 22448

Journal of Prostate Cancer
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Relevant Topics

Shashwat Sharad

Shashwat Sharad
Shashwat Sharad
Jr Staff Scientist at Center for Prostate Disease Research (CPDR), Uniformed Services University of Health Sciences, HJF
Washington, DC
USA
 

Biography

Dr. Sharad joined the Basic Science Research Program of Center for Prostate Disease Research (CPDR) in December 2009 as Postdoctoral Fellow and became Jr. Staff Scientist of in June 2015. He is working in the Section for Gene Regulation and Bioinformatics and in Gene Functions and Molecular Mechanisms section, at the Department of Surgery, Uniformed Services University of the Health Sciences (USUHS). He is also involved in integrating research activities within the translational research program at CPDR in collaboration with WRAMC and AFIP.

Dr. Sharad integrates prostate cancer research activities and do research efforts towards the exploration of regulation, expression and functions of prostate cancer and androgen --regulated genes. His scientific interests focus on understanding molecular mechanisms underlying cancer initiation and development. His specific goal is to determine key elements of prostate tumorigenesis, to identify biological functions of genes relevant to the development of normal prostate and prostate cancer (CaP) and to develop new approaches towards the treatment of CaP by synergizing state-of-the-art molecular biology, cancer biology, in silico bioinformatics and genetic engineered mouse model methodologies using in vivo and ex vivo approaches. He has an impressive and consistent publication record in quality scientific journals. He was invited speaker in several national and international conferences and served as reviewer for many of the peer-reviewed journals.

Research Interest

 Prostate Cancer, Nuclear Medicine

Leave Your Message 24x7
Top